Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $119,126 - $265,689
-3,224 Reduced 37.93%
5,276 $239,000
Q1 2022

May 13, 2022

SELL
$55.7 - $145.79 $417,750 - $1.09 Million
-7,500 Reduced 46.88%
8,500 $647,000
Q4 2021

Feb 09, 2022

BUY
$135.05 - $182.59 $459,170 - $620,806
3,400 Added 26.98%
16,000 $2.38 Million
Q3 2021

Nov 12, 2021

SELL
$145.58 - $192.14 $480,414 - $634,062
-3,300 Reduced 20.75%
12,600 $1.83 Million
Q2 2021

Aug 12, 2021

BUY
$134.22 - $202.37 $147,642 - $222,607
1,100 Added 7.43%
15,900 $3.11 Million
Q1 2021

May 13, 2021

SELL
$140.25 - $196.86 $785,400 - $1.1 Million
-5,600 Reduced 27.45%
14,800 $2.68 Million
Q4 2020

Feb 10, 2021

BUY
$126.47 - $163.7 $2.58 Million - $3.34 Million
20,400 New
20,400 $2.89 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.